Institute for Molecular Bacteriology

Hannover, Germany

Institute for Molecular Bacteriology

Hannover, Germany
SEARCH FILTERS
Time filter
Source Type

Vidigal P.G.,University of Duisburg - Essen | Musken M.,Institute for Molecular Bacteriology | Musken M.,Helmholtz Center for Infection Research | Becker K.A.,University of Duisburg - Essen | And 9 more authors.
PLoS ONE | Year: 2014

We investigated the in vitro and in vivo activities of epigallocatechin-3- gallate (EGCg), a green tea component, against Stenotrophomonas maltophilia (Sm) isolates from cystic fibrosis (CF) patients. In vitro effects of EGCg and the antibiotic colistin (COL) on growth inhibition, survival, and also against young and mature biofilms of S. maltophilia were determined. Qualitative and quantitative changes on the biofilms were assessed by confocal laser scanning microscopy (CLSM). Further, in vivo effects of nebulized EGCg in C57BL/6 and Cftr mutant mice during acute Sm lung infection were evaluated. Subinhibitory concentrations of EGCg significantly reduced not only biofilm formation, but also the quantity of viable cells in young and mature biofilms. CLSM showed that EGCg-exposed biofilms exhibited either a change in total biofilm biovolume or an increase of the fraction of dead cells contained within the biofilm in a dose depended manner. Sm infected wild-type and Cftr mutant mice treated with 1,024 mg/L EGCg by inhalation exhibited significantly lower bacterial counts than those undergoing no treatment or treated with COL. EGCg displayed promising inhibitory and anti-biofilm properties against CF Sm isolates in vitro and significantly reduced Sm bacterial counts in an acute infection model with wild type and CF mice. This natural compound may represent a novel therapeutic agent against Sm infection in CF. © 2014 Vidigal et al.


Godeke J.,Institute for Molecular Bacteriology | Pustelny C.,Helmholtz Center for Infection Research | Haussler S.,Helmholtz Center for Infection Research | Haussler S.,Institute for Molecular Bacteriology
Antimicrobial Agents and Chemotherapy | Year: 2013

Acute and chronic infections caused by the opportunistic pathogen Pseudomonas aeruginosa pose a serious threat to human health worldwide, and its increasing resistance to antibiotics requires alternative treatments that are more effective than available strategies. Clinical studies have clearly demonstrated that cystic fibrosis (CF) patients with chronic P. aeruginosa infections benefit from long-term low-dose azithromycin (AZM) treatment. Immunomodulating activity, the impact of AZM on the expression of quorum-sensing-dependent virulence factors, type three secretion, and motility in P. aeruginosa seem to contribute to the therapeutic response. However, to date, the molecular mechanisms underlying these AZM effects have remained elusive. Our data indicate that the AZM-mediated phenotype is caused by a depletion of the intracellular pools of tRNAs available for protein synthesis. Overexpression of the P. aeruginosa peptidyl-tRNA hydrolase, which recycles the tRNA from peptidyl-tRNA drop-off during translation, counteracted the effects of AZM on stationary-phase cell killing, cytotoxicity, and the production of rhamnolipids and partially restored swarming motility. Intriguingly, the exchange of a rare for a frequent codon in rhlR also explicitly diminished the AZM-mediated decreased production of rhamnolipids. These results indicate that depletion of the tRNA pools by AZM seems to affect the translation of genes that use rare aminoacyl-tRNA isoacceptors to a great extent and might explain the selective activity of AZM on the P. aeruginosa proteome and possibly also on the protein expression profiles of other bacterial pathogens. Copyright © 2013, American Society for Microbiology. All Rights Reserved.


Storz M.P.,Helmholtz Institute for Pharmaceutical Research Saarland HIPS | Maurer C.K.,Helmholtz Institute for Pharmaceutical Research Saarland HIPS | Zimmer C.,Helmholtz Institute for Pharmaceutical Research Saarland HIPS | Wagner N.,Helmholtz Institute for Pharmaceutical Research Saarland HIPS | And 11 more authors.
Journal of the American Chemical Society | Year: 2012

2-Heptyl-4-hydroxyquinoline (HHQ) and Pseudomonas quinolone signal (PQS) are involved in the regulation of virulence factor production and biofilm formation in Pseudomonas aeruginosa. PqsD is a key enzyme in the biosynthesis of these signal molecules. Using a ligand-based approach, we have identified the first class of PqsD inhibitors. Simplification and rigidization led to fragments with high ligand efficiencies. These small molecules repress HHQ and PQS production and biofilm formation in P. aeruginosa. This validates PqsD as a target for the development of anti-infectives. © 2012 American Chemical Society.

Loading Institute for Molecular Bacteriology collaborators
Loading Institute for Molecular Bacteriology collaborators